Canopy Growth Corp

WEED: XTSE (CAN)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
CAD 47.00XgzbKtth

Canopy Earnings: Shares Look Fairly Valued as Cannabis Positions Are Middling

After reviewing Canopy Growth's fiscal first-quarter earnings, we will likely reduce our fair value estimates of CAD 10.50/$7.70 by mid-single-digit percentages. Our cuts stem from weaker adult use in its Canadian market than we previously expected, partially offset by greater strength in the medical market. We don’t see enough margin of safety despite shares trading below our fair value estimates and recommend investors wait for a better entry point. We see better opportunity in no-moats Curaleaf and Green Thumb, given their more favorable exposure to the United States cannabis market.

Sponsor Center